Neoadjuvant radiotherapy followed by surgery can improve overall survival compared with surgery alone in certain patients with locally advanced rectal cancers, most notably in those with lower rectal ...
TNT achieved a 93.7% complete response rate and 87.5% organ preservation in stage I rectal cancer patients. TNT may offer an organ-preserving alternative to surgery, especially for low-lying tumors, ...
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Total ...
Adjuvant Chemotherapy after Surgery in Stage II and III Colon Cancer: The Sooner the Better? In surgically resectable disease, adjuvant chemotherapy has been clearly demonstrated to increase the ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research ...
Colorectal cancer is projected to impact more than 158,000 Americans in 2026. Learn about an immunotherapy-based treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results